Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ACTIVE NOT RECRUITING
NCT06516068
PHASE2
A Trial of HRS-1893 in Patients With Obstructive Hypertrophic Cardiomyopathy
Sponsor: Shandong Suncadia Medicine Co., Ltd.
View on ClinicalTrials.gov
Summary
The study is being conducted to evaluate the efficacy, and safety of HRS-1893 for obstructive hypertrophic cardiomyopathy
Official title: A Multicenter, Randomized, Open-label Phase II Clinical Study on the Efficacy and Safety of HRS-1893 in Obstructive Hypertrophic Cardiomyopathy Subjects.
Key Details
Gender
All
Age Range
18 Years - 85 Years
Study Type
INTERVENTIONAL
Enrollment
42
Start Date
2024-08-11
Completion Date
2025-08
Last Updated
2025-07-16
Healthy Volunteers
No
Conditions
Interventions
DRUG
HRS-1893
HRS-1893
Locations (1)
Fuwai Hospital Chinese Academy of Medical Sciences (CAMS)
Beijing, Beijing Municipality, China